Evidence map›Paper›PMID 34540827›Full record

ReviewFrontiers in cell and developmental biology2021

Advances in Understanding

Tamara Salloum, Sima Tokajian, Robert P Hirt

Abstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. PluronicInternational journal of molecular sciences · 2026
    Article
  3. Evaluation of Beauvericin's activity and mode of action against all life stages ofFrontiers in cellular and infection microbiology · 2025
    Article
  4. An update onParasite epidemiology and control · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Transcriptomic Profile of Canine DH82 Macrophages Infected byInternational journal of molecular sciences · 2022
    Article
  9. Article
  10. Dissection of the macrophage response towards infection by theFrontiers in cellular and infection microbiology · 2022
    Article
  11. Challenges and Tools for In VitroPathogens (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tamara SalloumDepartment of Natural Sciences, School of Arts and Sciences, Lebanese American University, Byblos, Lebanon.
Sima TokajianDepartment of Natural Sciences, School of Arts and Sciences, Lebanese American University, Byblos, Lebanon.
Robert P HirtFaculty of Medical Sciences, Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leishmaniasis is a vector-borne disease caused by a protozoa parasite from over 20

Indexed as

amastigotesgene expressionLeishmaniamacrophagesmetatranscriptomicspromastigotesRNA-Seqskin lesions

Identifiers

PMID34540827
PMCPMC8440825

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.